Contineum Therapeutics PEG Ratio

The latest PEG ratio for CTNM is 162.1. That is above the sector sector average of -7.59. Investors often review this figure alongside Contineum Therapeutics's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, CTNM currently prints 162.1 for PEG ratio, while the sector average sits near -7.59. That is roughly 2235.6% above the sector mean. Large gaps often invite a closer look at Contineum Therapeutics's growth, margins, and balance sheet.

A PEG ratio of 162.1 for Contineum Therapeutics is not 'good' or 'bad' on its own. Compare it with the peer average (-7.59) and with CTNM's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting CTNM's PEG ratio (162.1), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.